Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisomeTM
Authors:
- Raimunda Nonata Ribeiro SampaioRSRaimunda Nonata Ribeiro Sampaio
- Philip Davis MarsdenPMPhilip Davis Marsden
- 1 January 1997
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 91 (1) , 77
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Comparison of three treatment regimens with liposomal amphotericin B (AmBisome®) for visceral leishmaniasis in India: a randomized dose-finding studyTransactions of the Royal Society of Tropical Medicine and Hygiene, 1996
- Drug Resistance in Leishmaniasis: Its Implication in Systemic Chemotherapy of Cutaneous and Mucocutaneous DiseaseThe American Journal of Tropical Medicine and Hygiene, 1992
- Liposomal amphotericin B in drug-resistant visceral leishmaniasisThe Lancet, 1991
- Mucosal leishmaniasis (“spundia” Escomel, 1911)Transactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- PENTAVALENT ANTIMONIAL TREATMENT IN MUCOSAL LEISHMANIASISThe Lancet, 1985